Novel mediators of statin effects on plaque in HIV: a proteomics approach

Conclusion: This proof-of-concept study employing a proteomic discovery platform offers insight into statin effects on novel immune pathways relevant to ASCVD progression in HIV. Novel biomarker discovery may enhance precision medicine strategies to estimate the efficacy of targeted therapies to reduce ASCVD progression and events in HIV.
Source: AIDS - Category: Infectious Diseases Tags: Clinical Science Source Type: research